论文部分内容阅读
目的探讨消痔灵注射液结合手术治疗颌面颈部血管瘤的临床疗效。方法我院收治的颌面颈部血管瘤患者70例,随机分为观察组和对照组各35例。观察组患者均使用消痔灵注射液结合手术治疗。对照组患者均直接给予血管瘤切除术治疗。比较两组患者的术中出血量、肿瘤完整切除率、术后并发症情况以及术后复发率。结果观察组患者的术中出血量明显少于对照组患者(P<0.05);肿瘤完整切除率明显高于对照组患者(P<0.05);术后并发症发生率以及复发率均明显低于对照组患者(P<0.05)。结论消痔灵注射液结合手术治疗颌面颈部血管瘤具有操作简单,手术成功率高,术后并发症少,复发率低的特点,值得临床推广。
Objective To investigate the clinical efficacy of Xiaozhiling Injection combined with surgical treatment of maxillofacial and cervical hemangiomas. Methods 70 patients with maxillofacial and cervical hemangiomas admitted in our hospital were randomly divided into observation group and control group with 35 cases each. Observation group patients were treated with Xiaozhiling injection combined with surgical treatment. Patients in the control group were given hemangiomas directly. The blood loss, complete tumor resection rate, postoperative complications and postoperative recurrence were compared between the two groups. Results The intraoperative blood loss in the observation group was significantly less than that in the control group (P <0.05); the complete resection rate was significantly higher in the observation group than in the control group (P <0.05); the incidence of postoperative complications and the recurrence rate were significantly lower than those in the control group Control group patients (P <0.05). Conclusion Xiaozhiling injection combined with surgical treatment of maxillofacial and cervical hemangiomas has the advantages of simple operation, high operation success rate, less postoperative complications and low recurrence rate, which is worthy of clinical promotion.